Bridgeway Capital Management, LLC Finch Therapeutics Group, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.36 - $56.4 $36,000 - $5.64 Million
100,000 Added 155.6%
164,267 $78,000
Q3 2022

Nov 14, 2022
BUY
$1.75 - $51.3 $19,762 - $579,330
11,293 Added 21.32%
64,267 $107,000
Q2 2022

Aug 15, 2022
BUY
$1.91 - $5.11 $101,180 - $270,697
52,974 New
52,974 $150,000

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $575M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email